Cargando…

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient

We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Sánchez, Alejandro, Memon, Danish, Pourpe, Stephane, Veeraraghavan, Harini, Li, Yanyun, Vargas, Hebert Alberto, Gill, Michael B., Park, Kay J., Zivanovic, Oliver, Konner, Jason, Ricca, Jacob, Zamarin, Dmitriy, Walther, Tyler, Aghajanian, Carol, Wolchok, Jedd D., Sala, Evis, Merghoub, Taha, Snyder, Alexandra, Miller, Martin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589211/
https://www.ncbi.nlm.nih.gov/pubmed/28841418
http://dx.doi.org/10.1016/j.cell.2017.07.025
_version_ 1783262289653137408
author Jiménez-Sánchez, Alejandro
Memon, Danish
Pourpe, Stephane
Veeraraghavan, Harini
Li, Yanyun
Vargas, Hebert Alberto
Gill, Michael B.
Park, Kay J.
Zivanovic, Oliver
Konner, Jason
Ricca, Jacob
Zamarin, Dmitriy
Walther, Tyler
Aghajanian, Carol
Wolchok, Jedd D.
Sala, Evis
Merghoub, Taha
Snyder, Alexandra
Miller, Martin L.
author_facet Jiménez-Sánchez, Alejandro
Memon, Danish
Pourpe, Stephane
Veeraraghavan, Harini
Li, Yanyun
Vargas, Hebert Alberto
Gill, Michael B.
Park, Kay J.
Zivanovic, Oliver
Konner, Jason
Ricca, Jacob
Zamarin, Dmitriy
Walther, Tyler
Aghajanian, Carol
Wolchok, Jedd D.
Sala, Evis
Merghoub, Taha
Snyder, Alexandra
Miller, Martin L.
author_sort Jiménez-Sánchez, Alejandro
collection PubMed
description We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases were infiltrated by CD8(+) and CD4(+) T cells and exhibited oligoclonal expansion of specific T cell subsets. We also detected CD8(+) T cell reactivity against predicted neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were resected. These findings suggest that multiple distinct tumor immune microenvironments co-exist within a single individual and may explain in part the heterogeneous fates of metastatic lesions often observed in the clinic post-therapy. VIDEO ABSTRACT:
format Online
Article
Text
id pubmed-5589211
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-55892112017-09-15 Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient Jiménez-Sánchez, Alejandro Memon, Danish Pourpe, Stephane Veeraraghavan, Harini Li, Yanyun Vargas, Hebert Alberto Gill, Michael B. Park, Kay J. Zivanovic, Oliver Konner, Jason Ricca, Jacob Zamarin, Dmitriy Walther, Tyler Aghajanian, Carol Wolchok, Jedd D. Sala, Evis Merghoub, Taha Snyder, Alexandra Miller, Martin L. Cell Article We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases were infiltrated by CD8(+) and CD4(+) T cells and exhibited oligoclonal expansion of specific T cell subsets. We also detected CD8(+) T cell reactivity against predicted neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were resected. These findings suggest that multiple distinct tumor immune microenvironments co-exist within a single individual and may explain in part the heterogeneous fates of metastatic lesions often observed in the clinic post-therapy. VIDEO ABSTRACT: Cell Press 2017-08-24 /pmc/articles/PMC5589211/ /pubmed/28841418 http://dx.doi.org/10.1016/j.cell.2017.07.025 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jiménez-Sánchez, Alejandro
Memon, Danish
Pourpe, Stephane
Veeraraghavan, Harini
Li, Yanyun
Vargas, Hebert Alberto
Gill, Michael B.
Park, Kay J.
Zivanovic, Oliver
Konner, Jason
Ricca, Jacob
Zamarin, Dmitriy
Walther, Tyler
Aghajanian, Carol
Wolchok, Jedd D.
Sala, Evis
Merghoub, Taha
Snyder, Alexandra
Miller, Martin L.
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
title Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
title_full Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
title_fullStr Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
title_full_unstemmed Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
title_short Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
title_sort heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589211/
https://www.ncbi.nlm.nih.gov/pubmed/28841418
http://dx.doi.org/10.1016/j.cell.2017.07.025
work_keys_str_mv AT jimenezsanchezalejandro heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT memondanish heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT pourpestephane heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT veeraraghavanharini heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT liyanyun heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT vargashebertalberto heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT gillmichaelb heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT parkkayj heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT zivanovicoliver heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT konnerjason heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT riccajacob heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT zamarindmitriy heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT walthertyler heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT aghajaniancarol heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT wolchokjeddd heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT salaevis heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT merghoubtaha heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT snyderalexandra heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient
AT millermartinl heterogeneoustumorimmunemicroenvironmentsamongdifferentiallygrowingmetastasesinanovariancancerpatient